SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-96-026172
Filing Date
1996-11-14
Accepted
1996-11-14 00:00:00
Documents
6
Period of Report
1996-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 42972
2 EXHIBIT 10.39 STANDARD INDUSTRIAL LEASE EX-10.39 127367
3 EXHIBIT 10.40 BUSINESS LOAN AGREEMENT EX-10.40 42644
4 EXHIBIT 10.41 SUBLEASE AGREEMENT EX-10.41 37775
5 EXHIBIT 10.42 PROMISSORY NOTE EX-10.42 3545
6 EXHIBIT 27 FDS EX-27 2427
  Complete submission text file 0000912057-96-026172.txt   258761
Mailing Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080 4157378600
ARRIS PHARMACEUTICAL CORP/DE/ (Filer) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22788 | Film No.: 96662696
SIC: 2834 Pharmaceutical Preparations